Annual EBITDA
-$24.55 M
-$8.67 M-54.61%
December 31, 2022
Summary
- As of February 10, 2025, ACER annual EBITDA is -$24.55 million, with the most recent change of -$8.67 million (-54.61%) on December 31, 2022.
- During the last 3 years, ACER annual EBITDA has risen by +$5.29 million (+17.73%).
Performance
ACER EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly EBITDA
-$4.28 M
+$689.30 K+13.86%
June 30, 2023
Summary
- As of February 10, 2025, ACER quarterly EBITDA is -$4.28 million, with the most recent change of +$689.30 thousand (+13.86%) on June 30, 2023.
- Over the past year, ACER quarterly EBITDA has increased by +$2.76 million (+39.20%).
Performance
ACER Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM EBITDA
-$19.73 M
+$2.76 M+12.28%
June 30, 2023
Summary
- As of February 10, 2025, ACER TTM EBITDA is -$19.73 million, with the most recent change of +$2.76 million (+12.28%) on June 30, 2023.
- Over the past year, ACER TTM EBITDA has increased by +$2.00 million (+9.20%).
Performance
ACER TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ACER EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -54.6% | +39.2% | +9.2% |
| 3 y3 years | +17.7% | +25.5% | +7.0% |
| 5 y5 years | -76.0% | +12.8% | +33.9% |
ACER EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +54.6% | at low | at high | +64.5% | +24.3% | +24.4% |
| 5 y | 5-year | +54.6% | +21.6% | +31.4% | +64.5% | +24.3% | +51.2% |
| alltime | all time | >+9999.0% | +21.6% | -416.8% | +160.2% | >+9999.0% | +69.0% |
Acer Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | -$4.28 M(-13.9%) | -$19.73 M(-12.3%) |
| Mar 2023 | - | -$4.97 M(-5.3%) | -$22.50 M(-8.4%) |
| Dec 2022 | -$24.55 M(+54.6%) | -$5.25 M(+0.5%) | -$24.55 M(+3.6%) |
| Sep 2022 | - | -$5.23 M(-25.9%) | -$23.70 M(+9.0%) |
| Jun 2022 | - | -$7.05 M(+0.3%) | -$21.73 M(+18.8%) |
| Mar 2022 | - | -$7.03 M(+59.7%) | -$18.30 M(+15.2%) |
| Dec 2021 | -$15.88 M(-30.2%) | -$4.40 M(+35.0%) | -$15.88 M(-10.0%) |
| Sep 2021 | - | -$3.26 M(-9.7%) | -$17.63 M(-12.9%) |
| Jun 2021 | - | -$3.61 M(-21.6%) | -$20.24 M(-9.6%) |
| Mar 2021 | - | -$4.61 M(-25.2%) | -$22.38 M(-1.5%) |
| Dec 2020 | -$22.73 M(-23.8%) | -$6.15 M(+4.8%) | -$22.73 M(+4.5%) |
| Sep 2020 | - | -$5.87 M(+2.1%) | -$21.75 M(+2.5%) |
| Jun 2020 | - | -$5.75 M(+16.1%) | -$21.23 M(-20.3%) |
| Mar 2020 | - | -$4.95 M(-4.3%) | -$26.63 M(-10.8%) |
| Dec 2019 | -$29.84 M(+37.6%) | -$5.17 M(-3.3%) | -$29.84 M(-10.5%) |
| Sep 2019 | - | -$5.35 M(-52.0%) | -$33.35 M(+3.9%) |
| Jun 2019 | - | -$11.15 M(+36.5%) | -$32.11 M(+24.1%) |
| Mar 2019 | - | -$8.17 M(-6.0%) | -$25.87 M(+19.3%) |
| Dec 2018 | -$21.69 M(+55.5%) | -$8.69 M(+111.8%) | -$21.69 M(+26.0%) |
| Sep 2018 | - | -$4.10 M(-16.5%) | -$17.21 M(+4.5%) |
| Jun 2018 | - | -$4.91 M(+23.3%) | -$16.46 M(+34.6%) |
| Mar 2018 | - | -$3.98 M(-5.4%) | -$12.23 M(+33.4%) |
| Dec 2017 | -$13.95 M(+107.7%) | -$4.21 M(+25.5%) | -$9.17 M(+64.1%) |
| Sep 2017 | - | -$3.36 M(+394.9%) | -$5.59 M(+33.5%) |
| Jun 2017 | - | -$677.90 K(-26.8%) | -$4.19 M(-24.6%) |
| Mar 2017 | - | -$925.90 K(+46.9%) | -$5.55 M(-17.3%) |
| Dec 2016 | -$6.71 M(-42.8%) | -$630.30 K(-67.7%) | -$6.71 M(-20.3%) |
| Sep 2016 | - | -$1.95 M(-4.4%) | -$8.43 M(-8.3%) |
| Jun 2016 | - | -$2.04 M(-2.3%) | -$9.19 M(-13.0%) |
| Mar 2016 | - | -$2.09 M(-10.8%) | -$10.57 M(-10.0%) |
| Dec 2015 | -$11.74 M(-20.0%) | -$2.34 M(-13.8%) | -$11.74 M(-7.3%) |
| Sep 2015 | - | -$2.72 M(-20.4%) | -$12.66 M(-7.8%) |
| Jun 2015 | - | -$3.42 M(+4.6%) | -$13.73 M(-4.5%) |
| Mar 2015 | - | -$3.27 M(+0.1%) | -$14.38 M(-2.0%) |
| Dec 2014 | -$14.68 M(+4.5%) | -$3.26 M(-13.8%) | -$14.68 M(-2.8%) |
| Sep 2014 | - | -$3.78 M(-7.0%) | -$15.10 M(-9.1%) |
| Jun 2014 | - | -$4.07 M(+14.1%) | -$16.60 M(+9.5%) |
| Mar 2014 | - | -$3.57 M(-3.1%) | -$15.15 M(+7.8%) |
| Dec 2013 | -$14.05 M(+69.8%) | -$3.68 M(-30.4%) | -$14.05 M(+15.9%) |
| Sep 2013 | - | -$5.29 M(+101.7%) | -$12.13 M(+35.3%) |
| Jun 2013 | - | -$2.62 M(+6.4%) | -$8.97 M(+6.3%) |
| Mar 2013 | - | -$2.46 M(+40.2%) | -$8.43 M(+1.9%) |
| Dec 2012 | -$8.28 M(+43.8%) | -$1.76 M(-17.3%) | -$8.28 M(-0.8%) |
| Sep 2012 | - | -$2.13 M(+1.8%) | -$8.34 M(+11.9%) |
| Jun 2012 | - | -$2.09 M(-9.5%) | -$7.46 M(+9.9%) |
| Mar 2012 | - | -$2.31 M(+26.5%) | -$6.78 M(+17.9%) |
| Dec 2011 | -$5.76 M | -$1.82 M(+47.1%) | -$5.75 M(+19.1%) |
| Sep 2011 | - | -$1.24 M(-12.4%) | -$4.83 M(-0.3%) |
| Jun 2011 | - | -$1.42 M(+10.8%) | -$4.84 M(+0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2011 | - | -$1.28 M(+41.8%) | -$4.81 M(+0.2%) |
| Dec 2010 | -$4.80 M(+16.2%) | -$900.80 K(-28.1%) | -$4.80 M(-2.0%) |
| Sep 2010 | - | -$1.25 M(-9.3%) | -$4.90 M(+3.6%) |
| Jun 2010 | - | -$1.38 M(+8.9%) | -$4.73 M(+13.0%) |
| Mar 2010 | - | -$1.27 M(+26.7%) | -$4.19 M(+3.3%) |
| Dec 2009 | -$4.13 M(-64.8%) | -$1.00 M(-7.3%) | -$4.05 M(-18.6%) |
| Sep 2009 | - | -$1.08 M(+29.0%) | -$4.98 M(-28.7%) |
| Jun 2009 | - | -$837.40 K(-26.2%) | -$6.99 M(-28.5%) |
| Mar 2009 | - | -$1.13 M(-41.2%) | -$9.78 M(-16.6%) |
| Dec 2008 | -$11.73 M(-28.9%) | -$1.93 M(-37.6%) | -$11.73 M(-13.7%) |
| Sep 2008 | - | -$3.09 M(-14.9%) | -$13.60 M(-6.5%) |
| Jun 2008 | - | -$3.63 M(+17.7%) | -$14.54 M(-6.1%) |
| Mar 2008 | - | -$3.08 M(-18.7%) | -$15.49 M(-8.4%) |
| Dec 2007 | -$16.50 M(+24.0%) | -$3.79 M(-5.9%) | -$16.92 M(+3.5%) |
| Sep 2007 | - | -$4.03 M(-12.0%) | -$16.35 M(+3.1%) |
| Jun 2007 | - | -$4.58 M(+1.6%) | -$15.87 M(-0.9%) |
| Mar 2007 | - | -$4.51 M(+39.7%) | -$16.01 M(+20.2%) |
| Dec 2006 | -$13.31 M(+124.7%) | -$3.23 M(-9.0%) | -$13.31 M(-3.9%) |
| Sep 2006 | - | -$3.55 M(-24.9%) | -$13.86 M(+4.5%) |
| Jun 2006 | - | -$4.72 M(+160.4%) | -$13.26 M(+84.6%) |
| Mar 2006 | - | -$1.81 M(-51.9%) | -$7.18 M(+21.2%) |
| Dec 2005 | -$5.93 M(+116.1%) | -$3.77 M(+28.1%) | -$5.93 M(+76.0%) |
| Sep 2005 | - | -$2.95 M(-317.9%) | -$3.37 M(+230.7%) |
| Jun 2005 | - | $1.35 M(-342.8%) | -$1.02 M(-64.7%) |
| Mar 2005 | - | -$556.90 K(-54.2%) | -$2.89 M(+22.6%) |
| Dec 2004 | -$2.74 M(+2255.2%) | -$1.22 M(+103.6%) | -$2.35 M(+102.3%) |
| Sep 2004 | - | -$597.50 K(+15.7%) | -$1.16 M(+78.3%) |
| Jun 2004 | - | -$516.20 K(+2050.8%) | -$652.50 K(+300.8%) |
| Mar 2004 | - | -$24.00 K(-6.6%) | -$162.80 K(-4.3%) |
| Dec 2003 | - | -$25.70 K(-70.3%) | -$170.10 K(-4.3%) |
| Sep 2003 | -$116.40 K(-11.3%) | -$86.60 K(+226.8%) | -$177.70 K(+61.4%) |
| Jun 2003 | - | -$26.50 K(-15.3%) | -$110.10 K(-5.3%) |
| Mar 2003 | - | -$31.30 K(-6.0%) | -$116.30 K(-2.4%) |
| Dec 2002 | - | -$33.30 K(+75.3%) | -$119.10 K(-9.3%) |
| Sep 2002 | -$131.30 K(-75.2%) | -$19.00 K(-41.9%) | -$131.30 K(-50.3%) |
| Jun 2002 | - | -$32.70 K(-4.1%) | -$264.40 K(-20.7%) |
| Mar 2002 | - | -$34.10 K(-25.1%) | -$333.50 K(-21.6%) |
| Dec 2001 | - | -$45.50 K(-70.1%) | -$425.60 K(-19.6%) |
| Sep 2001 | -$529.40 K(-36.0%) | -$152.10 K(+49.4%) | -$529.40 K(-28.2%) |
| Jun 2001 | - | -$101.80 K(-19.3%) | -$737.70 K(-11.0%) |
| Mar 2001 | - | -$126.20 K(-15.5%) | -$828.80 K(-5.4%) |
| Dec 2000 | - | -$149.30 K(-58.6%) | -$875.80 K(+7.2%) |
| Sep 2000 | -$827.50 K(+137.7%) | -$360.40 K(+86.8%) | -$816.90 K(+38.7%) |
| Jun 2000 | - | -$192.90 K(+11.4%) | -$588.90 K(+11.2%) |
| Mar 2000 | - | -$173.20 K(+91.6%) | -$529.50 K(+27.5%) |
| Dec 1999 | - | -$90.40 K(-31.7%) | -$415.20 K(+20.1%) |
| Sep 1999 | -$348.20 K | -$132.40 K(-0.8%) | -$345.70 K(+62.1%) |
| Jun 1999 | - | -$133.50 K(+126.7%) | -$213.30 K(+167.3%) |
| Mar 1999 | - | -$58.90 K(+181.8%) | -$79.80 K(+281.8%) |
| Dec 1998 | - | -$20.90 K | -$20.90 K |
FAQ
- What is Acer Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Acer Therapeutics?
- What is Acer Therapeutics annual EBITDA year-on-year change?
- What is Acer Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Acer Therapeutics?
- What is Acer Therapeutics quarterly EBITDA year-on-year change?
- What is Acer Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Acer Therapeutics?
- What is Acer Therapeutics TTM EBITDA year-on-year change?
What is Acer Therapeutics annual EBITDA?
The current annual EBITDA of ACER is -$24.55 M
What is the all time high annual EBITDA for Acer Therapeutics?
Acer Therapeutics all-time high annual EBITDA is -$116.40 K
What is Acer Therapeutics annual EBITDA year-on-year change?
Over the past year, ACER annual EBITDA has changed by -$8.67 M (-54.61%)
What is Acer Therapeutics quarterly EBITDA?
The current quarterly EBITDA of ACER is -$4.28 M
What is the all time high quarterly EBITDA for Acer Therapeutics?
Acer Therapeutics all-time high quarterly EBITDA is $1.35 M
What is Acer Therapeutics quarterly EBITDA year-on-year change?
Over the past year, ACER quarterly EBITDA has changed by +$2.76 M (+39.20%)
What is Acer Therapeutics TTM EBITDA?
The current TTM EBITDA of ACER is -$19.73 M
What is the all time high TTM EBITDA for Acer Therapeutics?
Acer Therapeutics all-time high TTM EBITDA is -$20.90 K
What is Acer Therapeutics TTM EBITDA year-on-year change?
Over the past year, ACER TTM EBITDA has changed by +$2.00 M (+9.20%)